Sam-A Pharm. Co., Ltd (KOSDAQ:009300)
16,410
-160 (-0.97%)
At close: Apr 20, 2026
Sam-A Pharm. Revenue
In the year 2025, Sam-A Pharm. had annual revenue of 77.80B KRW, down -18.60%. Sam-A Pharm. had revenue of 20.76B in the quarter ending December 31, 2025, with 5.81% growth.
Revenue
77.80B
Revenue Growth
-18.60%
P/S Ratio
1.29
Revenue / Employee
255.08M
Employees
300
Market Cap
100.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 77.80B | -17.78B | -18.60% |
| Dec 31, 2024 | 95.58B | -1.63B | -1.68% |
| Dec 31, 2023 | 97.21B | 15.51B | 18.99% |
| Dec 31, 2022 | 81.70B | 27.03B | 49.45% |
| Dec 31, 2021 | 54.67B | 1.01B | 1.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ahn-Gook Pharmaceutical | 306.87B |
| Cosmax Nbt | 287.48B |
| H.PIO | 258.19B |
| Daehan Nupharm | 202.40B |
| Sinsin Pharmaceutical | 113.78B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 106.44B |
| Polaris AI Pharma | 63.94B |
| Samik Pharmaceutical Company LTD. | 60.02B |